+

WO2003053388A1 - Mousse deodorante - Google Patents

Mousse deodorante Download PDF

Info

Publication number
WO2003053388A1
WO2003053388A1 PCT/EP2002/014101 EP0214101W WO03053388A1 WO 2003053388 A1 WO2003053388 A1 WO 2003053388A1 EP 0214101 W EP0214101 W EP 0214101W WO 03053388 A1 WO03053388 A1 WO 03053388A1
Authority
WO
WIPO (PCT)
Prior art keywords
cosmetic product
product according
acid
esters
water
Prior art date
Application number
PCT/EP2002/014101
Other languages
German (de)
English (en)
Inventor
Bernhard Banowski
Claudia Weiler
Armin Wadle
Original Assignee
Henkel Kommanditgesellschaft Auf Aktien
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel Kommanditgesellschaft Auf Aktien filed Critical Henkel Kommanditgesellschaft Auf Aktien
Priority to EP02795159A priority Critical patent/EP1455743A1/fr
Publication of WO2003053388A1 publication Critical patent/WO2003053388A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/046—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26—Aluminium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof

Definitions

  • the present invention relates to cosmetic products which represent a new form of application for deodorant or antiperspirant active ingredients.
  • deodorant and antiperspirant compositions There are various forms of application for deodorant and antiperspirant compositions.
  • Anhydrous pens, creams and roll-ons as active ingredient suspensions leave a white, mostly greasy residue on skin and textiles.
  • Conventional pump atomizers bring the liquid deodorant or antiperspirant composition onto the skin as finely divided droplets. Often there is the disadvantage that the composition runs down in drops, depending on the amount applied. Roll-on formulations often have the disadvantage that they only dry slowly under the armpit.
  • the object of the present invention was to develop an application form for deodorant or antiperspirant compositions, which are preferably intended for use in the armpit, in which the composition remains at the original application site without leaving any visible residues. Another task was to provide a composition that left a fresh, pleasant feeling on the skin. Another task was to provide a composition which, through its appearance and consistency when applied, gives a nourishing impression.
  • liquid deodorant or antiperspirant compositions based on surfactant-containing, aqueous or aqueous-alcoholic solutions which are applied as spray foam, this foam being produced either with air or with volatile propellant gases and a suitable dispenser in each case becomes.
  • WO 01/24766 A1 discloses clear liquid or gel-like antiperspirant compositions in the form of microemulsions which contain a cosmetic oil, a cationic and a nonionic surfactant. It will numerous dosage forms have been proposed for these compositions, including a mousse. However, specific references to the formulation of foamed compositions are not disclosed.
  • a liquid aqueous composition comprising a foaming surfactant, for example cocamidopropyl betaine, a foam-stabilizing surfactant, for example stearamine oxide, a polymer, for example polyquaternium-10, and a component for lowering viscosity, the released from a compressible plastic container with a foam-generating spray head as foam for wet shaving.
  • a foaming surfactant for example cocamidopropyl betaine
  • a foam-stabilizing surfactant for example stearamine oxide
  • a polymer for example polyquaternium-10
  • a component for lowering viscosity the released from a compressible plastic container with a foam-generating spray head as foam for wet shaving.
  • WO 91/17237 discloses aqueous cleaning compositions containing a combination of selected amphoteric surfactants and optionally antibacterial active ingredients which are released as foam from a compressible propellant-gas-free plastic container with a foam-generating spray head. No indication of use as an antiperspirant foam is disclosed.
  • the published patent application EP 570 619 A1 discloses a cleaning process for hard surfaces with an aerosol foam, the foam being produced from an aqueous cleaner composition containing alkyl polyglycoside surfactants and optionally ethanol using propellants.
  • a reference to a cosmetic use, in particular as an antiperspirant foam, is not disclosed.
  • a first object of the present invention is a cosmetic product for the foam application of a deodorant or antiperspirant active substance, consisting of a foam dispenser which is operated either with air or with a volatile propellant gas and from a liquid, foaming surfactant solution which contains water or a water-ethanol Mixture as carrier, at least one foaming surfactant, at least one oil component liquid at 25 ° C., at least one perfume oil, contains at least one nonionic hydrophilic solubilizer for the perfume oil and at least one deodorant or antiperspirant active ingredient.
  • water or the water-ethanol mixture are present in amounts of 61-95% by weight, preferably 65-90% by weight, based in each case on the total surfactant solution.
  • the ethanol content, if present, is 0.1 according to the invention
  • the foam produced suggests the use of a cream without showing the residual behavior of a suspension or emulsion.
  • the composition was chosen so that the foam on the skin collapses relatively quickly due to mechanical stress.
  • the composition leaves a fresh impression on the skin and shows little, if any, stickiness.
  • the addition of cosmetic oils serves to increase the nourishing skin feeling.
  • the composition according to the invention can be colored with dyes, so that a colored foam is formed.
  • Another object of the present invention is a non-therapeutic method for reducing odor or sweating, in which an effective amount of a liquid, foaming surfactant solution containing water or a water-ethanol mixture as a carrier, at least one foaming surfactant, at least one 25 ° C liquid oil component, at least one perfume oil, at least one nonionic hydrophilic solubilizer for the perfume oil and at least one deodorant or antiperspirant active ingredient, from a foam dispenser, which is operated either with air or with a volatile propellant gas, is applied as a foam to the skin.
  • Foaming nonionic surfactants suitable according to the invention are, for example
  • R 1 CO represents a linear or branched, saturated and / or unsaturated acyl radical having 6 to 22 carbon atoms
  • R 2 represents hydrogen or methyl
  • R 3 represents linear or branched alkyl radicals having 1 to 4 carbon atoms and x represents numbers from 1 to 20,
  • alkyl polygycosides according to the general formula RO- (Z) x where R is a C 8 -C 16 alkyl group, Z is sugar and x is the number of sugar units.
  • the alkyl polyglycosides which can be used according to the invention may contain only one specific alkyl radical R. Usually, however, these compounds are made from natural fats and oils or mineral oils. In this case, the alkyl radicals R are mixtures corresponding to the starting compounds or corresponding to the respective working up of these compounds.
  • R consists essentially of C 8 and do alkyl groups, essentially of C 12 and C 14 alkyl groups, essentially of C 8 to C 16 alkyl groups or essentially of C 12 to C 16 alkyl groups.
  • Any mono- or oligosaccharides can be used as sugar building block Z.
  • Sugars with 5 or 6 carbon atoms and the corresponding oligosaccharides are usually used, for example glucose, fructose, galactose, arabinose, ribose, xylose, lyxose, allose, old rose, mannose, gulose, idose, talose and sucrose.
  • Preferred sugar units are glucose, fructose, galactose, arabinose and sucrose; Glucose is particularly preferred.
  • the alkyl polyglycosides which can be used according to the invention contain on average 1.1 to 5, preferably 1.1 to 2.0, particularly preferably 1.1 to 1.8 sugar units.
  • the alkoxylated homologs of the alkyl polyglycosides mentioned can also be used according to the invention. These homologues can contain an average of up to 10 ethylene oxide and / or propylene oxide units per alkyl glycoside unit.
  • Zwitterionic surfactants are surface-active compounds that contain at least one quaternary ammonium group and at least one - COO (_) - or -SO 3 (" ⁇ group in the molecule.
  • Particularly suitable zwitterionic surfactants are so-called betaines such as N-alkyl N, N-dimethylammonium glycinate, for example the coconut alkyldimethylammonium glycinate, N-acylaminopropyl-N, N-dimethylammonium glycinate, for example the coconut acylaminopropyldimethylammonium glycinate, and 2-alkyl-3-carboxymethyl-3-hydroxyethylimidazolines each having 8 to 18 C-atoms Alkyl or acyl group and cocoacylaminoethylhydroxyethylcarboxymethylglycinate
  • a preferred zwitterionic surfactant is the fatty acid amide derivative known under the INCI name Cocamido
  • Suitable anionic surfactants in preparations according to the invention are all anionic surface-active substances suitable for use on the human body. These are characterized by a water-solubilizing, anionic group such as. B. a carboxylate, sulfate, sulfonate or phosphate group and a lipophilic alkyl group with about 8 to 30 carbon atoms.
  • the molecule can contain glycol or polyglycol ether groups, ester, ether and amide groups and hydroxyl groups.
  • suitable foaming anionic surfactants are, in each case in the form of the sodium, potassium and ammonium and the mono-, di- and trialkanolammonium salts with 2 to 4 carbon atoms in the alkanol group,
  • R 1 CO represents a linear or branched acyl radical having 6 to 22 carbon atoms and 0, 1, 2 or 3 double bonds and X represents hydrogen, an alkali metal and / or alkaline earth metal, ammonium, alkylammonium, alkanolammonium or glucammonium, for example Acyl glutamates derived from fatty acids with 6 to 22, preferably 12 to 18 carbon atoms, such as C 12 / ⁇ - or Ci 2 / ⁇ 8 coconut fatty acid, lauric acid, myristic acid, palmitic acid and / or stearic acid, especially sodium N- cocoyl and sodium N-stearoyl-L-glutamate,
  • esters of a hydroxy-substituted di- or tricarboxylic acid of the general formula (II)
  • X H or a -CH 2 COOR group
  • R, R 1 and R 2 are independent of each other is a hydrogen atom, an alkali or alkaline earth metal cation, an ammonium group, the cation of an ammonium organic base or a radical Z which is derived from a polyhydroxylated organic compound which consists of the group of etherified (C 6 -C 8 ) alkyl polysaccharides with 1 to 6 monomeric saccharide units and / or the etherified aliphatic (C 6 -C 16 ) - hydroxyalkyl polyols with 2 to 16 hydroxyl radicals are selected, provided that at least one of the Groups R, R 1 or R 2 is a radical Z,
  • R 3 represents a hydrogen atom, an alkali or alkaline earth metal cation, an ammonium group or the cation of an ammonium organic base
  • R 1 and R 2 independently of one another represent a hydrogen atom, an alkali or alkaline earth metal cation, an ammonium group, the cation of an ammonium -Organic base or a radical Z which derives from a polyhydroxylated organic compound which belongs to the group of etherified (C 6 -C 18 ) -alkyl polysaccharides with 1 to 6 monomeric saccharide units and / or the etherified aliphatic (C 6 -C 16 ) Hydroxyalkyl polyols having 2 to 16 hydroxyl radicals is selected, provided that at least one of the groups R 1 or R 2 is a Z radical,
  • Esters of tartaric acid and citric acid with alcohols which are adducts of about 2-15 molecules of ethylene oxide and / or propylene oxide with fatty alcohols having 8 to 22 carbon atoms,
  • Acyl taurates with a linear or branched acyl radical having 6 to 22 carbon atoms and 0, 1, 2 or 3 double bonds,
  • OX in R 1 is preferably an aliphatic hydrocarbon radical having 8 to 30 carbon atoms
  • R 2 is hydrogen, a radical (CH 2 CH 2 O) n R 1 or X, n is a number from 1 to 10 and X is hydrogen, an alkali - or alkaline earth metal or NR 3 R 4 R 5 R 6 , with R 3 to R 6 independently of one another representing a Ci to C 4 hydrocarbon radical,
  • R 7 CO sulfated fatty acid alkylene glycol esters of the formula R 7 CO (AlkO) n SO 3 M
  • R 7 CO is a linear or branched, aliphatic, saturated and / or unsaturated acyl radical having 6 to 22 C atoms
  • alk is CH 2 CH 2 , CHCH 3 CH 2 and / or CH 2 CHCH 3
  • n stands for numbers from 0.5 to 5
  • M stands for a cation, as described in DE-OS 197 36 906.5
  • V Monoglyceride sulfates and monoglyceride ether sulfates of the formula (V)
  • R 8 CO stands for a linear or branched acyl radical with 6 to 22 carbon atoms, x, y and z in total for 0 or for numbers from 1 to 30, preferably 2 to 10, and X stands for an alkali or alkaline earth metal.
  • Typical examples of monoglyceride (ether) suIfate suitable for the purposes of the invention are the reaction products of lauric acid monoglyceride, coconut fatty acid monoglyceride, palmitic acid monoglyceride, stearic acid monoglyceride, oleic acid monoglyceride and tallow fatty acid monoglyceride as well as their ethylene oxide adducts or their sulfur sulfonate adducts with sodium sulfate trioxide in their form of sulfuric acid adducts with their sulfur sulfonate adducts with sulfuric acid trioxide or their formulas with sulfuric acid trioxide.
  • Monoglyceride sulfates of the formula (IV) are preferably used, in which R 8 CO stands for a linear acyl radical having 8 to 18 carbon atoms.
  • Preferred anionic surfactants are acyl glutamates, acyl isethionates, acyl sarcosinates and acyl taurates, each with a linear or branched acyl radical having 6 to 22 carbon atoms and 0, 1, 2 or 3 double bonds, which in particularly preferred embodiments consists of an octanoyl, decanoyl, lauroyl, Myristoyl, palmitoyl and stearoyl radical is selected, esters of tartaric acid, citric acid or succinic acid or the salts of these acids with alkylated glucose, in particular the products with the INCI name Disodium Coco-Glucoside Citrate, Sodium Coco-Glucoside Tartrate and Disodium Coco- Glucoside sulfosuccinates, alkyl polyglycol ether sulfates and ether carboxylic acids with 8 to 18 C atoms in the alkyl group and up to 12 ethoxy groups in the molecule, s
  • Foaming cationic surfactants of the type of the quaternary ammonium compounds, the esterquats and the amidoamines are also suitable according to the invention.
  • Preferred quaternary ammonium compounds are ammonium halides, especially chlorides and bromides, such as alkyl trimethyl ammonium chlorides, dialkyl dimethyl ammonium chlorides and trialkyl methyl ammonium chlorides, e.g. B.
  • cetyltrimethylammonium chloride stearyltrimethylammonium chloride, distearyldimethylammonium chloride, lauryldimethylammonium chloride, lauryldimethylbenzylammonium chloride and tricetylmethylammonium chloride, as well as the compounds known under the INCI names Quatemium-27 and Quaternium-83.
  • the long alkyl chains of the above-mentioned surfactants preferably have 10 to 18 carbon atoms.
  • Esterquats are known substances which contain both at least one ester function and at least one quaternary ammonium group as a structural element.
  • Preferred ester quats are quaternized ester salts of fatty acids with triethanolamine, quaternized ester salts of fatty acids with diethanolalkylamines and quaternized ester salts of fatty acids with 1,2-dihydroxypropyldialkylamines.
  • Such products are sold, for example, under the trademarks Stepantex ® , Dehyquart ® and Armocare ® .
  • the products Armocare ® VGH-70, an N, N-bis (2-palmitoyloxyethyl) dimethylammonium chloride, as well as Dehyquart ® F-75, Dehyquart ® C-4046, Dehyquart ® L80 and Dehyquart ® AU-35 are examples of such esterquats .
  • the alkylamidoamines are usually produced by amidation of natural or synthetic fatty acids and fatty acid cuts with dialkylaminoamines.
  • An inventively particularly suitable compound from this group of substances that available under the name Tegoamid ® S 18 commercially stearamidopropyldimethylamine is dimethylamine.
  • Esterquats are particularly preferred cationic surfactants according to the invention. In a particularly preferred embodiment, only nonionic surfactants are contained.
  • compositions according to the invention contain the foaming surfactant in amounts of 0.1-5% by weight, preferably 0.2-3% by weight and particularly preferably 0.4-2, in each case based on the total liquid composition.
  • Oil components that are liquid according to the invention at 25 ° C. are, for example
  • branched primary alcohols in particular Guerbet alcohols based on fatty alcohols having 6 to 22, preferably 8 to 10, carbon atoms,
  • esters of saturated or unsaturated, linear or branched C 3 -C 22 fatty acids or the dimers of unsaturated C 12 -C 22 fatty acids (dimer fatty acids) with a) monovalent linear, branched or cyclic C 2 -C 22 alkanols , b) polyvalent linear or branched C 2 -C 6 alkanols, c) polyglycerols of the formula CH 2 OH-CHOH-CH 2 [-O-CH 2 -CHOH-CH 2 J n -O-CH 2 -CHOH-CH 2 OH with n 0 - 8, or d) the dicarboxylic and tricarboxylic esters of linear and branched C 2 -C 10 alkanols, wherein as preferred components a) esters of linear C 6 - C 22 fatty acids with linear C 6 -C 22 fatty alcohols, so-called wax Sesterheim, provided they are liquid at 25 ° C, such as Jo
  • Esters of linear and branched C 12 -C 22 alkanols of mono- and polyvalent C 2 -C 7 hydroxycarboxylic acids which can be aromatic, in particular benzoic acid (eg Finsolv ® TN),
  • Dialkyl ether e.g. B. dioctyl ether (Cetiol ® OE),
  • Aliphatic hydrocarbons e.g. B. paraffin oils and isoparaffin oils
  • alicyclic hydrocarbons containing no atoms other than carbon and hydrogen e.g. B. substituted cyclohexanes such as 1,3-bis (2-ethylhexyl) cyclohexane (Cetiol ® S),
  • compositions according to the invention contain the oil component which is liquid at 25 ° C. in amounts of 0.1-5% by weight, preferably 0.5-3% by weight, in each case based on the total liquid composition.
  • Perfume oils include mixtures of natural and synthetic fragrances. Natural fragrances are extracts of flowers (lily, lavender, roses, jasmine, neroli, ylang-ylang), stems and leaves (geranium, patchouli, petitgrain), fruits (anise, coriander, caraway, juniper), fruit peel (bergamot, lemon, Oranges), roots (mace, angelica, celery, cardamom, costus, iris, calmus), wood (pine, sandal, guaiac, cedar, rosewood), herbs and grasses (tarragon, lemongrass, sage, thyme), Needles and twigs (spruce, fir, pine, mountain pine), resins and balms (galbanum, elemi, benzoin, myrrh, olibanum, opoponax).
  • fragrance compounds are products of the ester, ether, aldehyde, ketone, alcohol and hydrocarbon type.
  • Fragrance compounds of the ester type are, for example, benzyl acetate, phenoxyethyl isobutyrate, p-tert-butylcyclohexyl acetate, linalyl acetate, dimethylbenzylcarbinylacetate, phenylethyl acetate, linalyl benzoate, benzyl formate, ethyl methylphenyl glycinate, allyl cyclohexyl benzylatepylpropionate, stally.
  • the ethers include, for example, benzyl ethyl ether, the aldehydes, for example, the linear alkanals with 8-18 C atoms, citral, citronellal, citronellyloxyacetaldehyde, cyclamenaldehyde, hydroxycitronellal, lilial and bourgeonal, the ketones, for example, the jonones, ⁇ -isomethylionone and methylcedryl ketone the alcohols anethole, citronellol, eugenol, isoeugenol, geraniol, linalool, phenylethyl alcohol and terpineol, the hydrocarbons mainly include the terpenes and balsams.
  • fragrance oils of lower volatility which are mostly used as aroma components, are also suitable as perfume oils, e.g. sage oil, chamomile oil, clove oil, lemon balm oil, mint oil, cinnamon leaf oil, linden blossom oil, juniper berry oil, vetiver oil, oliban oil, gaibanum oil, labolanum oil and lavandin oil.
  • compositions according to the invention contain the perfume oil in amounts of 0.01-2% by weight, preferably 0.1-1% by weight, in each case based on the total liquid composition.
  • Nonionic hydrophilic solubilizers suitable according to the invention are selected from the adducts of 4 to 100 ethylene oxide units with optionally hardened mono-, di- and triglycerides of C 8-22 fatty acids, the adducts of 5 to 40 ethylene oxide units with C 8-22 Fatty alcohols and the adducts of 2 to 50 ethylene oxide units and 2 to 35 propylene oxide units with C 3 -C 5 alkanols.
  • Examples of ethoxylated mono-, di- and triglycerides of C 8-22 fatty acids with 4 up to 60 ethylene oxide units are hydrogenated ethoxylated castor oil (INCI name, e.g.
  • PEG-40 Hydrogenated Cator Oil olive oil ethoxylate (INCI name: PEG-10 Olive Glycerides), almond oil ethoxylate, mink oil ethoxylate, polyoxyethylene glycol caprylic / capric acid glycerides, polyoxyethylene and polycerethylene moncerol glycolkokosfettklastedreglyceride.
  • suitable C 8-22 ethoxylated fatty alcohols are Laureth-12, Laureth-23, Trideceth-8, Ceteareth-12, Ceteareth-15, Ceteareth-20, Ceteareth-30, Steareth-10, Steareth-15, Steareth-20 , Steareth-30, Steareth-40, Oleth-10 or Oleth-20.
  • compositions according to the invention contain the nonionic hydrophilic solubilizer in amounts of 0.1-7% by weight, preferably 0.5-6% by weight and particularly preferably 1-4% by weight,
  • Suitable antiperspirant active substances according to the invention are water-soluble astringent or protein-coagulating metallic salts, in particular inorganic and organic salts of aluminum, zirconium, zinc and titanium and any mixtures of these salts.
  • water solubility means a solubility of at least 4 g of active substance per 100 g of solution at 20 ° C.
  • alum (KAI (SO) 2 ⁇ 12 H 2 O), aluminum sulfate, aluminum lactate, sodium aluminum chlorohydroxyctate, aluminum chlorohydroxy allantoinate, aluminum chlorohydrate, aluminum sulfocarbolate, aluminum zirconium chlorohydrate, zinc chloride, zinc sulfocarbolate, zinc sulfate, zirconium chlorohydrate can be used according to the invention.
  • the liquid active substance preparations preferably contain an astringent aluminum salt, in particular aluminum chlorohydrate, and / or an aluminum-zirconium compound.
  • Umchlorohydrate aluminum for example, powdery Micro Dry ® Ultrafine or distributed as in activated form as Reach ® 501 or Reach ® 103 from Reheis and in the form of aqueous solutions as Locron ® L of Clariant ® or as Chlorhydrol from Reheis.
  • An aluminum sesquichlorohydrate from Reheis is sold under the name Reach ® 301 offered.
  • the antiperspirant active ingredient in the compositions according to the invention is in an amount of 0.01-40% by weight, preferably 2-30% by weight and in particular 5-25% by weight, based on the amount of the active substance in the total liquid Composition.
  • the antiperspirant compositions which contain one of the abovementioned antiperspirant active ingredients are formulated without an anionic surfactant and instead with nonionic, zwitterionic and / or cationic surfactants in order to avoid deactivation of the active ingredient by precipitation.
  • Suitable as deodorants according to the invention are fragrances, antimicrobial, antibacterial or germ-inhibiting substances, enzyme-inhibiting substances, antioxidants and odor adsorbents.
  • Suitable antimicrobial, antibacterial or antimicrobial substances are in particular CrQralkanols, C 2 -C 4 -alkanediols, organohalogen compounds and halides, quaternary ammonium compounds, a number of plant extracts and zinc compounds.
  • Halogenated phenol derivatives such as. B.
  • hexachlorophene or Irgasan DP 300 (triclosan, 2,4,4'-trichloro-2'-hydroxydiphenyl ether), 3,4,4'-trichlorocarbonilide, chlorhexidine (1,1'-hexamethylene-bis- [5- (4th -chlorophenyl)] - biguanide), chlorhexidine gluconate, benzalkonium halides and cetyl pyridinium chloride.
  • deodorant active substances Even weaker-acting antimicrobial substances, which, however, have a specific effect against the gram-positive germs responsible for the decomposition of sweat, can be used as deodorant active substances.
  • Aromatic alcohols such as. B. benzyl alcohol, 2-phenylethanol or 2-phenoxyethanol can be used as deodorant active ingredients.
  • Other antibacterial deodorants are lantibiotics, glycoglycerolipids, sphingolipids (ceramides), sterols and other active ingredients that inhibit bacterial adhesion to the skin, e.g. B.
  • suitable long chain diols e.g. B. 1,2-alkane (C 8 -C 18 ) diol, glycerol mono- (C 6 -C 6 ) alkyl ether or glycerol mono (C 8 -C 18 ) fatty acid ester, which is very well tolerated by the skin and mucous membranes and against Corynebacteria are effective.
  • Deodorising substances which inhibit ester-splitting enzymes and in this way counteract the decomposition of perspiration are particularly deodorising as enzyme-inhibiting substances.
  • Antioxidative substances can counteract the oxidative decomposition of the welding components and thus inhibit the development of odors.
  • Suitable antioxidants are amino acids (e.g. glycine, histidine, tyrosine, tryptophan) and their derivatives, imidazole and imidazole derivatives (e.g. urocanic acid), peptides such as. B. D, L-carosene, D-carnosine, L-camosine and their derivatives (e.g. anserine), carotenoids, carotenes (e.g. ⁇ -carotene, ß-carotene, lycopene) and their derivatives, Lipoic acid and its derivatives (e.g.
  • thioglycerin thiosorbitol, thioglycolic acid, thioredoxin, glutathione, cysteine, cystine, cystamine and their glycosyl, N-acetyl- Methyl, ethyl, propyl, amyl, butyl, lauryl, palmitoyl, oleyl, ⁇ -linoleyl, cholesteryl and glyceryl esters
  • salts dilaurylthiodipropionate, distearylthiodipropionate, thiodipropionic acid and their derivatives (esters, ethers , Peptides, lipids, nucleotides, nucleosides and salts) as well as sulfoximine compounds (e.g.
  • buthionine sulfoximines in very low tolerable dosages (e.g. pmol / kg to ⁇ mol / kg), furthermore metal chelators (e.g. ⁇ -hydroxy fatty acids, EDTA, EGTA, phytic acid right, lactoferrin), ⁇ -hydroxy acids (e.g. B. citric acid, lactic acid, malic acid), humic acids, bile acid, bile extracts, gallic acid esters (e.g.
  • octyl and dodecyl gallate flavonoids
  • catechins bilirubin
  • biliverdin and their derivatives unsaturated fatty acids and their derivatives (e.g. ⁇ -linolenic acid, linoleic acid, arachidonic acid, oleic acid), folic acid and its derivatives, hydroquinone and its derivatives (e.g. arbutin), ubiquinone and ubiquinol as well as their derivatives, vitamin C and its derivatives (e.g.
  • vitamin A palmitate the coniferyl benzoate of benzoin, rutin, rutinic acid and their derivatives, disodium rutinyl disulfate, cinnamic acid and their derivatives (e.g. ferulic acid, ethyl ferulate, caffeic acid), kojic acid, chitosan glycolate and salicylate, butylated hydroxytoluene, butylated hydroxyanisole, nordihydroguajak resin acid, nordihydrogu undonroxyne derivatives, trihydroxybenzoic acid, trihydroxybenzoate, trihydroxylacid, Derivatives, zinc and zinc derivatives (e.g.
  • ZnO, ZnSO 4 selenium and selenium derivatives (e.g. selenium methionine), stilbenes and stilbene derivatives (e.g. stilbene oxide, trans-stilbene oxide).
  • suitable derivatives salts, esters, sugars, nucleotides, nucleosides, peptides and lipids
  • mixtures of these active substances mentioned or plant extracts e.g. tea tree oil, rosemary extract and rosemary acid
  • Preferred lipophilic, oil-soluble antioxidants from this group are tocopherol and its derivatives, gallic acid esters, flavonoids and carotenoids, and butylated hydroxytoluene / anisole.
  • water-soluble antioxidants are amino acids, e.g. B. tyrosine and cysteine and their derivatives and tannins, especially those of plant origin are preferred.
  • the total amount of the antioxidants in the liquid compositions according to the invention is 0.001-10% by weight, preferably 0.05-5% by weight and in particular 0.05-2% by weight, based on the total liquid composition.
  • the following substances can be used as odor absorbers: zinc ricinoleate, cyclodextrin and its derivatives, hydroxypropyl- ⁇ -cyclodextrin, furthermore oxides such as magnesium oxide or zinc oxide, the oxides not being compatible with aluminum chlorohydrate, furthermore starch and starch derivatives, silicas, which may have been modified , Zeolites, talc and synthetic polymers, for example Nylon.
  • Complex-forming substances can also support the deodorising effect by stably complexing the oxidatively catalytically active heavy metal ions (e.g. iron or copper).
  • Suitable complexing agents are e.g. B. the salts of ethylenediaminetetraacetic acid or nitrilotriacetic acid and the salts of 1-hydroxyethane-1,1-diphosphonic acid.
  • the compositions according to the invention further contain at least one water-soluble polyol, selected from water-soluble diols, triols and higher alcohols and polyethylene glycols.
  • the diols are C 2 -C 12 diols, in particular 1, 2-propylene glycol, butylene glycols such as. B. 1,2-butylene glycol, 1,3-butylene glycol and 1,4-butylene glycol, pentanediols, e.g. B. 1,2-pentanediol, and hexanediols, e.g. B. 1, 6-hexanediol.
  • glycerol and technical oligoglycerol mixtures with a degree of self-condensation of 1.5 to 10 such as technical diglycerol mixtures with a diglycerol content of 40 to 50% by weight or triglycerol, furthermore 1, 2,6-hexanetriol and polyethylene glycols (PEG). with an average molecular weight of 100 to 1,000 daltons, for example PEG-400, PEG-600 or PEG-1000.
  • PEG polyethylene glycols
  • Other suitable higher alcohols are the C -, C 5 - and C 6 -monosaccharides and the corresponding sugar alcohols, e.g. B. mannitol or sorbitol.
  • compositions according to the invention contain the water-soluble polyol in amounts of 1-50% by weight, preferably 1-15% by weight and particularly preferably 1-5% by weight, in each case based on the total liquid composition.
  • Suitable foam dispensers that are operated without volatile propellant gases are e.g. B. Squeeze bottles made of compressible plastic.
  • containers made of different materials can be provided with a pump, in which, for. B. introduced through porous bodies or sieves air into the surfactant solution and so the surfactant solution is discharged as a foam.
  • containers made of different materials with a nozzle, e.g. B. a fan jet nozzle or a pneumatic nozzle, which also allows the discharge of a foamed surfactant solution.
  • Suitable foam dispensers that are operated with volatile propellants are aerosol containers made of aluminum, tinplate, plastic or glass, which can be coated on the inside, with a suitable spray valve. Due to the compressed blowing agent contained, for. B. carbon dioxide, isobutane, butane, propane, pentane, isopentane, fluorocarbons or dimethyl ether, the surfactant solution is foamed when exiting.
  • the compressed blowing agent contained, for. B. carbon dioxide, isobutane, butane, propane, pentane, isopentane, fluorocarbons or dimethyl ether.
  • the amounts in% by weight relate to the content of active substance. production method
  • the oil components were homogenized with the solubilizer and optionally with ethanol.
  • the foaming surfactants were then added.
  • water and optionally the polyols were added.
  • the finished compositions 1, 2 or 3 were filled into a propellant-free spray container (Airfoamer F2, manufacturer: Airspray International B.V.).
  • the finished composition 4 was filled with a butane / isobutane propellant gas mixture in the propellant gas: composition weight ratio of 4:96 into an aerosol can made of internally coated aluminum.
  • the finished composition 5 was filled with a butane / isobutane propellant gas mixture in the propellant gas composition weight ratio of 5:95 into an aerosol can made of internally coated tinplate.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne un procédé pour réduire le développement d'odeur ou de sueur, ainsi qu'un produit cosmétique à appliquer sous forme de mousse et comportant un agent actif déodorant ou antitranspirant. Ce produit est constitué d'un distributeur de mousse fonctionnant au moyen d'air ou de gaz propulseur volatil et d'une composition moussante fluide, laquelle contient de l'eau ou un mélange eau-éthanol en tant que support, au moins un tensioactif moussant, au moins un composant huileux liquide à 25 °C, au moins une huile de parfum, au moins un agent de solubilisation hydrophile non ionique pour l'huile de parfum et au moins un agent actif déodorant ou antitranspirant.
PCT/EP2002/014101 2001-12-21 2002-12-12 Mousse deodorante WO2003053388A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP02795159A EP1455743A1 (fr) 2001-12-21 2002-12-12 Mousse deodorante

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2001163247 DE10163247A1 (de) 2001-12-21 2001-12-21 Deodorant-Schaum
DE10163247.9 2001-12-21

Publications (1)

Publication Number Publication Date
WO2003053388A1 true WO2003053388A1 (fr) 2003-07-03

Family

ID=7710370

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2002/014101 WO2003053388A1 (fr) 2001-12-21 2002-12-12 Mousse deodorante

Country Status (3)

Country Link
EP (1) EP1455743A1 (fr)
DE (1) DE10163247A1 (fr)
WO (1) WO2003053388A1 (fr)

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005048966A1 (fr) * 2003-11-17 2005-06-02 The Procter & Gamble Company Composition antitranspirante et applicateur associe
WO2008049650A1 (fr) * 2006-10-26 2008-05-02 Beiersdorf Ag Formulation cosmétique ou dermatologique comprenant de l'acide mandélique et des adjuvants
WO2010097205A3 (fr) * 2009-02-27 2011-11-10 Beiersdorf Ag Utilisation de tensio-actifs chargés pour diminuer la formation de taches sur des textiles par des anti-transpirants
EP2735301A1 (fr) * 2012-11-23 2014-05-28 Beiersdorf AG Utilisation de triéthylcitrate comme dénaturant pour l'éthanol
GB2516261A (en) * 2013-07-16 2015-01-21 Solent Internat Ltd Cleaning product
US9687425B2 (en) 2014-06-30 2017-06-27 The Procter & Gamble Company Personal care compositions and methods
US9717930B2 (en) 2013-03-12 2017-08-01 The Procter & Gamble Company Antiperspirant compositions
US9802900B2 (en) 2013-03-15 2017-10-31 Global Blood Therapeutics, Inc. Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin
US9877909B2 (en) 2014-06-30 2018-01-30 The Procter & Gamble Company Personal care compositions and methods
US10016343B2 (en) 2013-03-12 2018-07-10 The Procter & Gamble Company Solid stick antiperspirant compositions
US20220062494A1 (en) * 2018-12-13 2022-03-03 Basf Se Odor-inhibiting compositions and hygienic articles incorporating the same
WO2022235542A1 (fr) * 2021-05-03 2022-11-10 The Procter & Gamble Company Compositions de mousse
WO2022235543A1 (fr) * 2021-05-03 2022-11-10 The Procter & Gamble Company Compositions de mousse
USD998474S1 (en) 2020-11-25 2023-09-12 The Procter & Gamble Company Aerosol dispenser
US11827443B2 (en) 2021-05-03 2023-11-28 The Procter & Gamble Company Aerosol foam dispenser
USD1015881S1 (en) 2021-05-03 2024-02-27 The Procter & Gamble Company Aerosol foam dispenser

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1576946A1 (fr) * 2004-03-18 2005-09-21 Henkel Kommanditgesellschaft auf Aktien Utilisation de inhibiteurs de coques gram positif dans des deodorants et des antitranspirants
DE102004051420A1 (de) * 2004-10-22 2006-05-04 Merz Pharma Gmbh & Co. Kgaa Treibgasfreie schaumbildende, insbesondere hypoallergene Systeme für pharmazeutisch-dermatologische, kosmetische und hygienische Anwendungen und deren Herstellung

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3630065A1 (de) * 1985-09-04 1987-03-05 Osaka Aerosol Ind Corp Aerosol-zusammensetzung
EP0447142A1 (fr) * 1990-03-12 1991-09-18 Unilever Plc Compositions transparentes pour bâtons cosmétiques
WO1991017237A1 (fr) * 1990-04-27 1991-11-14 The Procter & Gamble Company Produits de toilette
WO2001024766A1 (fr) * 1999-10-01 2001-04-12 Unilever Plc Compositions antisudorifiques comprenant des microemulsions

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3630065A1 (de) * 1985-09-04 1987-03-05 Osaka Aerosol Ind Corp Aerosol-zusammensetzung
EP0447142A1 (fr) * 1990-03-12 1991-09-18 Unilever Plc Compositions transparentes pour bâtons cosmétiques
WO1991017237A1 (fr) * 1990-04-27 1991-11-14 The Procter & Gamble Company Produits de toilette
WO2001024766A1 (fr) * 1999-10-01 2001-04-12 Unilever Plc Compositions antisudorifiques comprenant des microemulsions

Cited By (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005048966A1 (fr) * 2003-11-17 2005-06-02 The Procter & Gamble Company Composition antitranspirante et applicateur associe
US7905673B2 (en) 2003-11-17 2011-03-15 The Procter & Gamble Company Antiperspirant composition and applicator therefor
WO2008049650A1 (fr) * 2006-10-26 2008-05-02 Beiersdorf Ag Formulation cosmétique ou dermatologique comprenant de l'acide mandélique et des adjuvants
WO2010097205A3 (fr) * 2009-02-27 2011-11-10 Beiersdorf Ag Utilisation de tensio-actifs chargés pour diminuer la formation de taches sur des textiles par des anti-transpirants
US8691250B2 (en) 2009-02-27 2014-04-08 Beiersdorf Ag Use of charged surfactants for reducing textile staining by antiperspirants
US10172773B2 (en) 2009-02-27 2019-01-08 Beiersdorf Ag Use of charged surfactants for reducing textile staining by antiperspirants
EP3111916A1 (fr) * 2009-02-27 2017-01-04 Beiersdorf AG Utilisation de tensioactifs charges destines a reduire les taches au moyen d'anti-transpirants
EP3120828A1 (fr) * 2009-02-27 2017-01-25 Beiersdorf AG Utilisation de tensioactifs charges destines a reduire les taches au moyen d'anti-transpirants
US10111818B2 (en) 2009-02-27 2018-10-30 Beiersdorf Ag Use of charged surfactants for reducing textile staining by antiperspirants
US10105300B2 (en) 2009-02-27 2018-10-23 Beiersdorf Ag Use of charged surfactants for reducing textile staining by antiperspirants
EP2735301A1 (fr) * 2012-11-23 2014-05-28 Beiersdorf AG Utilisation de triéthylcitrate comme dénaturant pour l'éthanol
US9937113B2 (en) 2013-03-12 2018-04-10 The Procter & Gamble Company Antiperspirant compositions
US10052271B2 (en) 2013-03-12 2018-08-21 The Procter & Gamble Company Antiperspirant compositions
US9717930B2 (en) 2013-03-12 2017-08-01 The Procter & Gamble Company Antiperspirant compositions
US10016343B2 (en) 2013-03-12 2018-07-10 The Procter & Gamble Company Solid stick antiperspirant compositions
US9802900B2 (en) 2013-03-15 2017-10-31 Global Blood Therapeutics, Inc. Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin
GB2516261A (en) * 2013-07-16 2015-01-21 Solent Internat Ltd Cleaning product
US9750671B2 (en) 2014-06-30 2017-09-05 The Procter & Gamble Company Personal care compositions and methods
US9687425B2 (en) 2014-06-30 2017-06-27 The Procter & Gamble Company Personal care compositions and methods
US10154949B2 (en) 2014-06-30 2018-12-18 The Procter & Gamble Company Personal care compositions and methods
US9877909B2 (en) 2014-06-30 2018-01-30 The Procter & Gamble Company Personal care compositions and methods
US10413493B2 (en) 2014-06-30 2019-09-17 The Procter & Gamble Company Personal care composition and methods
US10716743B2 (en) 2014-06-30 2020-07-21 The Procter & Gamble Company Personal care compositions and methods
US20220062494A1 (en) * 2018-12-13 2022-03-03 Basf Se Odor-inhibiting compositions and hygienic articles incorporating the same
USD998474S1 (en) 2020-11-25 2023-09-12 The Procter & Gamble Company Aerosol dispenser
WO2022235542A1 (fr) * 2021-05-03 2022-11-10 The Procter & Gamble Company Compositions de mousse
WO2022235543A1 (fr) * 2021-05-03 2022-11-10 The Procter & Gamble Company Compositions de mousse
US11827443B2 (en) 2021-05-03 2023-11-28 The Procter & Gamble Company Aerosol foam dispenser
USD1015881S1 (en) 2021-05-03 2024-02-27 The Procter & Gamble Company Aerosol foam dispenser

Also Published As

Publication number Publication date
DE10163247A1 (de) 2003-07-03
EP1455743A1 (fr) 2004-09-15

Similar Documents

Publication Publication Date Title
EP1455743A1 (fr) Mousse deodorante
EP3013429B1 (fr) Utilisation de n-methyl-n-acylglucamines spéciales dans des détergents pour vaisselle à la main
EP1406587A2 (fr) Composition a base de cire
EP1351653B1 (fr) Emulsions a base d'emulsifiants speciaux
DE10102543A1 (de) Emulsionen auf Basis spezieller Emulgatoren
WO2002003927A2 (fr) Aerosols
EP1212033B1 (fr) Composition cosmetique
WO2000027343A2 (fr) Preparations cosmetiques et/ou pharmaceutiques
WO2021052856A1 (fr) Concentrés de stabilisant pour dispersions de cire
EP1200043A2 (fr) Produit de protection solaire
EP1200062A1 (fr) Dispersions aqueuses de lustre perlaire contenant des esters d'acide carboxylique alcoxylee
WO2020182784A1 (fr) Concentrés stabilisants pour dispersions de cire
EP1475077B1 (fr) Compositions anti-transpirantes liquides à deux phases
WO2000020551A1 (fr) Detergent synthetique sous forme de pains de savon
WO2004083351A1 (fr) Melanges d'agents tensioactifs
DE19821402A1 (de) Verfahren zur Herstellung von stabilen Emulsionen
EP1021163A1 (fr) Produits cosmetiques
DE19858812A1 (de) Desodorierende kosmetische Mittel
DE10259406A1 (de) Milde Detergensgemische
WO1999066895A1 (fr) Preparations cosmetiques sous forme de baton
WO2001072950A1 (fr) Savon liquide
WO2001010999A1 (fr) Savonnettes
DE19814065A1 (de) Hautpflegemittel
DE19810888A1 (de) Wäßrige Perlglanzdispersionen

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): PL RU US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SI SK TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2002795159

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2002795159

Country of ref document: EP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载